JOSE DAVID: Open Payments
NPI 1831181981 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,112 in 174 payments from 37 companies in 2025. Trend: 2023 $27,567 · 2024 $21,527 · 2025 $16,112
Speaker / faculty: $9,879Food & beverage: $5,038Travel & lodging: $1,195
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 15 | $8,566 |
| ABBVIE INC. | 27 | $3,377 |
| AstraZeneca Pharmaceuticals LP | 15 | $872 |
| Lilly USA, LLC | 13 | $370 |
| Braeburn Inc. | 9 | $215 |
| Novo Nordisk Inc | 5 | $214 |
| Alkermes, Inc. | 4 | $198 |
| Alnylam Pharmaceuticals Inc. | 4 | $192 |
| Vanda Pharmaceuticals Inc. | 8 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $159 |
Products named: SPRAVATO, QULIPTA, FARXIGA, REXULTI, UBRELVY, BREZTRI, BRIXADI, GIVLAARI.
Industry payments across NY — which companies pay providers there.
